The lawsuit stated that Gilead knew of TDF's side effects, but minimized or omitted information about those risks. It also stated that Gilead intentionally held back the release of a safer HIV drug in order to protect its patent on the less safe drug.[52] On Friday May 10, 2020, U.S. District Judge Jon S. Tigar ruled that the litigation may proceed.[53]